Sotera Health Company
Financials
Valuation Metrics
Sotera Health Company's Market Cap is $5.06B. At end of 2025 it was $5.01B. Ranked #1312 of 3,118 in US market (top 42%), #437 of 1,474 on NASDAQ (top 30%), #87 of 203 in Health Care Equipment & Services (top 43%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $5.06B | US#1,312/3,118 Sec#87/203 |
| Revenue | $1.22B | US#1,751/3,118 Sec#109/203 |
| Net Income | $163M | US#1,392/3,118 Sec#70/203 |
| Total Assets | $3.31B | US#1,736/3,118 Sec#82/203 |
| Net Assets | $666M | US#2,040/3,118 Sec#108/203 |
| Employees | 3,000 | US#1,468/3,118 Sec#104/203 |
| Value | ||
| P/E | 30.93x | US#1,621/3,118 Sec#61/203 |
| P/B | 7.60x | US#2,514/3,118 Sec#157/203 |
| PEG | 0.05x | US#131/3,118 Sec#5/203 |
| P/S | 4.16x | US#2,145/3,118 Sec#141/203 |
| EV/EBITDA | 12.92x | US#1,257/3,118 Sec#42/203 |
| FCF Yield | 2.23% | US#1,996/3,118 Sec#119/203 |
| Profitability | ||
| ROE | 24.56% | US#427/3,118 Sec#20/203 |
| ROA | 4.94% | US#1,052/3,118 Sec#66/203 |
| Op. Margin | 36.24% | US#370/3,118 Sec#4/203 |
| Revenue Growth | 8.15% | US#1,429/3,118 Sec#102/203 |
| Earnings Growth | 580.51% | US#59/3,118 Sec#3/203 |
| Financial Health | ||
| Debt Ratio | 396.78% | US#2,257/3,118 Sec#178/203 |
| Total Debt | $2.27B | US#1,091/3,118 Sec#52/203 |
| FCF | $113M | US#1,678/3,118 Sec#98/203 |
| Cash | $357M | US#1,288/3,118 Sec#76/203 |
| Current Ratio | 2.80x | US#847/3,118 Sec#87/203 |
| Net Debt/EBITDA | 3.54x | US#1,757/3,118 Sec#112/203 |
| Dividend | ||
| Div. Growth | 240.16% | US#38/3,118 Sec#3/203 |
| Performance | ||
| 1Y Return | 6.81% | US#1,447/3,118 Sec#110/203 |
| 1M Return | -2.69% | US#1,953/3,118 Sec#147/203 |
| From 52W High | -10.68% | US#693/3,118 Sec#66/203 |
| 1Y MDD | -32.14% | US#1,451/3,118 Sec#77/203 |
| Trading | ||
| Volume | 2,609,145 shares | US#835/3,118 Sec#43/203 |
| Trading Value | $47M | US#1,434/3,118 Sec#103/203 |
| Per Share | ||
| EPS | $0.57 | US#1,840/3,118 Sec#103/203 |
| BPS | $2.33 | US#2,542/3,118 Sec#168/203 |
Company Info
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.